Personalized Paths: Unlocking Alzheimer's via the Gut-Brain Axis

Area of Science:

• Neuroscience
• Microbiology
• Gastroenterology

Background:

• Alzheimer's disease (AD) is characterized by brain protein aggregates causing cognitive decline.
• Current AD therapies manage symptoms; disease-modifying treatments are critically needed.
• Alterations in gut microbiota composition are observed in AD patients, suggesting a gut-brain axis link.

Purpose of the Study:

• To review microbial interventions for Alzheimer's disease.
• To explore the potential of fecal microbiota transplantation, probiotics, and diet.
• To emphasize personalized approaches for AD treatment and research.

Main Methods:

• Narrative review of existing studies on microbial interventions in AD.
• Analysis of microbiota composition changes and effects on cognitive function.
• Discussion of the need for integrated analysis of microbiome, clinical, and lifestyle data.

Main Results:

• Microbial interventions like FMT, probiotics, and diet may alter microbiota composition.
• Some studies indicate beneficial effects of these interventions on cognitive function.
• The precise mechanisms of action for microbial interventions in AD remain unclear.

Conclusions:

• Personalized treatment strategies considering individual metabolic and microbiome profiles are essential for AD.
• Further research is needed to understand the mechanisms of microbial interventions.
• Integrating microbiota analysis with clinical and lifestyle data is vital for a comprehensive understanding of AD.